Case Report: Successful treatment of severe pneumocystis carinii pneumonia in a case series of primary nephrotic syndrome after receiving anti-CD20 monoclonal antibody therapy

• Main Authors: Lili Liu (Author), Weihua Zheng (Author), Ping Wang (Author), Ying Wu (Author), Guanghua Zhu (Author), Rong Yang (Author), Li Gu (Author), Wenyan Huang (Author), Yulin Kang (Author)
• Format: Book
• Published: Frontiers Media S.A., 2023-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Rituximab is emerging as a new steroid sparing agent in children with difficult-to-treat nephrotic syndrome due to its ability of depleting CD20-positive B cells. Life-threatening adverse events such as pneumocystis carinii pneumonia may occur even though it seems to be well tolerated. Since rituxim...